Cargando…
Seroprevalence of antibodies to SARS‐CoV‐2 in healthcare workers in a nonepidemic region, Japan: A hospital‐based study on May, 2020
The polymerase chain reaction (PCR) testing rate is low in our local area and the true rate of coronavirus disease 2019 (COVID‐19) infection may include many asymptomatic individuals. We conducted a serosurveillance using antibody testing in an area where official report of COVID‐19 infection is not...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250612/ https://www.ncbi.nlm.nih.gov/pubmed/33760273 http://dx.doi.org/10.1002/jmv.26962 |
_version_ | 1783717061057314816 |
---|---|
author | Nakamura, Akihiro Ando, Sanae Endo, Hideaki Sato, Ryoichi |
author_facet | Nakamura, Akihiro Ando, Sanae Endo, Hideaki Sato, Ryoichi |
author_sort | Nakamura, Akihiro |
collection | PubMed |
description | The polymerase chain reaction (PCR) testing rate is low in our local area and the true rate of coronavirus disease 2019 (COVID‐19) infection may include many asymptomatic individuals. We conducted a serosurveillance using antibody testing in an area where official report of COVID‐19 infection is not done yet. Blood samples were obtained from 1404 healthcare workers (41 ± 11 years) in our hospital on May 29–31, 2020. First, the potential infection frequency was confirmed using two quantitative antibody tests. In addition, the usefulness of rapid antibody kit testing for COVID‐19 serosurveillance was examined. A COVID‐19‐indected case was defined as showing positive results in both quantitative tests. None of 1404 samples had positive results from the two quantitative tests. The false positive rates were 0.36% and 0.07%, whereas those in rapid antibody kits were 3.3% and 3.0%. In conclusion, as of May, 2020, potential spread mainly by asymptomatic individuals infected with COVID‐19 was not found in our local area where there was no official report of COVID‐19, even if the PCR testing rate was low. Rapid antibody kits might not be useful due to the high false positive rate in an area with a low incidence of COVID‐19 infected individuals. |
format | Online Article Text |
id | pubmed-8250612 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82506122021-07-02 Seroprevalence of antibodies to SARS‐CoV‐2 in healthcare workers in a nonepidemic region, Japan: A hospital‐based study on May, 2020 Nakamura, Akihiro Ando, Sanae Endo, Hideaki Sato, Ryoichi J Med Virol Short Communications The polymerase chain reaction (PCR) testing rate is low in our local area and the true rate of coronavirus disease 2019 (COVID‐19) infection may include many asymptomatic individuals. We conducted a serosurveillance using antibody testing in an area where official report of COVID‐19 infection is not done yet. Blood samples were obtained from 1404 healthcare workers (41 ± 11 years) in our hospital on May 29–31, 2020. First, the potential infection frequency was confirmed using two quantitative antibody tests. In addition, the usefulness of rapid antibody kit testing for COVID‐19 serosurveillance was examined. A COVID‐19‐indected case was defined as showing positive results in both quantitative tests. None of 1404 samples had positive results from the two quantitative tests. The false positive rates were 0.36% and 0.07%, whereas those in rapid antibody kits were 3.3% and 3.0%. In conclusion, as of May, 2020, potential spread mainly by asymptomatic individuals infected with COVID‐19 was not found in our local area where there was no official report of COVID‐19, even if the PCR testing rate was low. Rapid antibody kits might not be useful due to the high false positive rate in an area with a low incidence of COVID‐19 infected individuals. John Wiley and Sons Inc. 2021-04-03 2021-07 /pmc/articles/PMC8250612/ /pubmed/33760273 http://dx.doi.org/10.1002/jmv.26962 Text en © 2021 The Authors. Journal of Medical Virology published by Wiley Periodicals LLC https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Short Communications Nakamura, Akihiro Ando, Sanae Endo, Hideaki Sato, Ryoichi Seroprevalence of antibodies to SARS‐CoV‐2 in healthcare workers in a nonepidemic region, Japan: A hospital‐based study on May, 2020 |
title | Seroprevalence of antibodies to SARS‐CoV‐2 in healthcare workers in a nonepidemic region, Japan: A hospital‐based study on May, 2020 |
title_full | Seroprevalence of antibodies to SARS‐CoV‐2 in healthcare workers in a nonepidemic region, Japan: A hospital‐based study on May, 2020 |
title_fullStr | Seroprevalence of antibodies to SARS‐CoV‐2 in healthcare workers in a nonepidemic region, Japan: A hospital‐based study on May, 2020 |
title_full_unstemmed | Seroprevalence of antibodies to SARS‐CoV‐2 in healthcare workers in a nonepidemic region, Japan: A hospital‐based study on May, 2020 |
title_short | Seroprevalence of antibodies to SARS‐CoV‐2 in healthcare workers in a nonepidemic region, Japan: A hospital‐based study on May, 2020 |
title_sort | seroprevalence of antibodies to sars‐cov‐2 in healthcare workers in a nonepidemic region, japan: a hospital‐based study on may, 2020 |
topic | Short Communications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250612/ https://www.ncbi.nlm.nih.gov/pubmed/33760273 http://dx.doi.org/10.1002/jmv.26962 |
work_keys_str_mv | AT nakamuraakihiro seroprevalenceofantibodiestosarscov2inhealthcareworkersinanonepidemicregionjapanahospitalbasedstudyonmay2020 AT andosanae seroprevalenceofantibodiestosarscov2inhealthcareworkersinanonepidemicregionjapanahospitalbasedstudyonmay2020 AT endohideaki seroprevalenceofantibodiestosarscov2inhealthcareworkersinanonepidemicregionjapanahospitalbasedstudyonmay2020 AT satoryoichi seroprevalenceofantibodiestosarscov2inhealthcareworkersinanonepidemicregionjapanahospitalbasedstudyonmay2020 |